English

American Renal Holdings Inc.

EDGAR

Quarterly report (10-Q) · filed 2012-11-09

9 filing records in this dataset, filed from 2010-11-04 to 2012-11-09. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

92.7 million USD

2011-09-30 · USD

Exact inputs and evidence

Revenue: 92666000 USD Source

Operating margin

24.19%

2011 Q3 · %

Exact inputs and evidence

Operating Income: 22416000 USD Source
Revenue: 92666000 USD Source

Operating cash flow

36.4 million USD

2011-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: 63903000 USD Source
Operating Cash Flow: 27507000 USD Source

Free cash flow

30.7 million USD

2011-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: 63903000 USD Source
Operating Cash Flow: 27507000 USD Source
Capital Expenditure: 14559000 USD Source
Capital Expenditure: 8827000 USD Source

Cash and cash equivalents: 32.1 million USD 2011-12-31 Source
Exact value

32136000 USD
Long-term debt including current maturities: 260 million USD 2012-09-30 Source
Exact value

260315000 USD
Shares outstanding: 1 thousand shares 2012-09-30 Source
Exact value

1000 shares

Reported share-count change

0.00% · 0 shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

1000 shares · 2011-09-30· Source
1000 shares · 2012-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Operating cash flow

99.1 million USD

2011-10-01 – 2012-09-30

Exact inputs and evidence

Operating cash flow: 80287000 USD · 2011-01-01 – 2011-12-31 Source
Operating cash flow: 63903000 USD · 2011-01-01 – 2011-09-30 Source
Operating cash flow: 23846000 USD · 2012-01-01 – 2012-03-31 Source
Operating cash flow: 50223000 USD · 2012-01-01 – 2012-06-30 Source
Operating cash flow: 23846000 USD · 2012-01-01 – 2012-03-31 Source
Operating cash flow: 82685000 USD · 2012-01-01 – 2012-09-30 Source
Operating cash flow: 50223000 USD · 2012-01-01 – 2012-06-30 Source

Capital expenditure

27.9 million USD

2011-10-01 – 2012-09-30

Exact inputs and evidence

Capital expenditure: 21908000 USD · 2011-01-01 – 2011-12-31 Source
Capital expenditure: 14559000 USD · 2011-01-01 – 2011-09-30 Source
Capital expenditure: 6133000 USD · 2012-01-01 – 2012-03-31 Source
Capital expenditure: 14483000 USD · 2012-01-01 – 2012-06-30 Source
Capital expenditure: 6133000 USD · 2012-01-01 – 2012-03-31 Source
Capital expenditure: 20582000 USD · 2012-01-01 – 2012-09-30 Source
Capital expenditure: 14483000 USD · 2012-01-01 – 2012-06-30 Source

Free cash flow

71.1 million USD

2011-10-01 – 2012-09-30

Exact inputs and evidence

Operating cash flow: 80287000 USD · 2011-01-01 – 2011-12-31 Source
Operating cash flow: 63903000 USD · 2011-01-01 – 2011-09-30 Source
Operating cash flow: 23846000 USD · 2012-01-01 – 2012-03-31 Source
Operating cash flow: 50223000 USD · 2012-01-01 – 2012-06-30 Source
Operating cash flow: 23846000 USD · 2012-01-01 – 2012-03-31 Source
Operating cash flow: 82685000 USD · 2012-01-01 – 2012-09-30 Source
Operating cash flow: 50223000 USD · 2012-01-01 – 2012-06-30 Source
Capital expenditure: 21908000 USD · 2011-01-01 – 2011-12-31 Source
Capital expenditure: 14559000 USD · 2011-01-01 – 2011-09-30 Source
Capital expenditure: 6133000 USD · 2012-01-01 – 2012-03-31 Source
Capital expenditure: 14483000 USD · 2012-01-01 – 2012-06-30 Source
Capital expenditure: 6133000 USD · 2012-01-01 – 2012-03-31 Source
Capital expenditure: 20582000 USD · 2012-01-01 – 2012-09-30 Source
Capital expenditure: 14483000 USD · 2012-01-01 – 2012-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2012-11-09.

Financial data available through: 2010-12-31.

Financial coverage is incomplete. Newer filings are recorded, but comparable financial figures for those periods are not available here yet.

Coverage by financial measure

Revenue: 2 of 11 periods available· newest 2010-12-31
Operating income: 2 of 11 periods available· newest 2010-12-31
Net income: 2 of 11 periods available· newest 2010-12-31
Operating cash flow: 2 of 11 periods available· newest 2010-12-31
Capital expenditure: 2 of 11 periods available· newest 2010-12-31
Total assets: 1 of 11 periods available· newest 2010-12-31
liabilities: No compatible figures in this window
Current assets: 1 of 11 periods available· newest 2010-12-31
Current liabilities: 1 of 11 periods available· newest 2010-12-31
Cash and cash equivalents: 1 of 11 periods available· newest 2010-12-31
long term debt: No compatible figures in this window
Shares outstanding: 1 of 11 periods available· newest 2010-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-17.2%

Prior period

USD 262.99 million

2009-01-02 – 2010-01-01
Current period

USD 217.78 million

2010-01-01 – 2010-12-31

Exact inputs and evidence

217777000 − 262989000 = -45212000 USD

262989000 USD · 2009-01-02 – 2010-01-01
Inspect prior input Prior source
217777000 USD · 2010-01-01 – 2010-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · American Renal Holdings Inc. · 2010-12-31 American Renal Holdings Inc. (edgar:1504735) Year-over-year change in Revenue: -45212000 USD Concept: fundies:Revenue Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T15:00:46Z Snapshot: a09bfe715aa9e843feb83d550b3410bfeefdea652b2179faa0f5d02e386742c5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1504735?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 217777000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1504735/0001193125-11-084560.txt#11399 Input fundies:Revenue: 262989000 USD (2009-01-02 to 2010-01-01) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1504735/0001193125-11-084560.txt#11399
The citation records this snapshot. The page link may show a newer release later.
Net income
-29.1%

Prior period

USD 5.14 million

2009-01-02 – 2010-01-01
Current period

USD 3.64 million

2010-01-01 – 2010-12-31

Exact inputs and evidence

3644000 − 5138000 = -1494000 USD

5138000 USD · 2009-01-02 – 2010-01-01
Inspect prior input Prior source
3644000 USD · 2010-01-01 – 2010-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · American Renal Holdings Inc. · 2010-12-31 American Renal Holdings Inc. (edgar:1504735) Year-over-year change in Net income: -1494000 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T15:00:46Z Snapshot: a09bfe715aa9e843feb83d550b3410bfeefdea652b2179faa0f5d02e386742c5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1504735?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 3644000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1504735/0001193125-11-084560.txt#11741 Input fundies:NetIncome: 5138000 USD (2009-01-02 to 2010-01-01) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1504735/0001193125-11-084560.txt#11741
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-49.5%

Prior period

USD 51.33 million

2009-01-01 – 2009-12-31
Current period

USD 25.94 million

2010-01-01 – 2010-12-31

Exact inputs and evidence

25943000 − 51331000 = -25388000 USD

51331000 USD · 2009-01-01 – 2009-12-31
Inspect prior input Prior source
25943000 USD · 2010-01-01 – 2010-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · American Renal Holdings Inc. · 2010-12-31 American Renal Holdings Inc. (edgar:1504735) Year-over-year change in Operating cash flow: -25388000 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T15:00:46Z Snapshot: a09bfe715aa9e843feb83d550b3410bfeefdea652b2179faa0f5d02e386742c5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1504735?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 25943000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1504735/0001193125-11-084560.txt#16896 Input fundies:OperatingCashFlow: 51331000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1504735/0001193125-11-084560.txt#16896
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-8.4%

Prior period

USD 15.07 million

2009-01-01 – 2009-12-31
Current period

USD 13.8 million

2010-01-01 – 2010-12-31

Exact inputs and evidence

13804000 − 15067000 = -1263000 USD

15067000 USD · 2009-01-01 – 2009-12-31
Inspect prior input Prior source
13804000 USD · 2010-01-01 – 2010-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · American Renal Holdings Inc. · 2010-12-31 American Renal Holdings Inc. (edgar:1504735) Year-over-year change in Capital expenditure: -1263000 USD Concept: fundies:CapitalExpenditure Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T15:00:46Z Snapshot: a09bfe715aa9e843feb83d550b3410bfeefdea652b2179faa0f5d02e386742c5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1504735?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 13804000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1504735/0001193125-11-084560.txt#16940 Input fundies:CapitalExpenditure: 15067000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1504735/0001193125-11-084560.txt#16940
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2010 2010-01-01 – 2010-12-31

Revenue USD 217.78 million 100% of revenue
Operating costs Derived USD 176.37 million 81% of revenue
Operating income USD 41.41 million 19% of revenue
Tax, interest and other Derived USD 37.77 million 17% of revenue
Net income USD 3.64 million 1.7% of revenue

Cash

Operating cash flow USD 25.94 million 12% of revenue
Capital expenditure USD 13.8 million 6.3% of revenue
Free cash flow Derived USD 12.14 million 5.6% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2010 18%80%
2010 17%81%

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2010 2009-01-02 – 2010-01-01	262989000	210988000 Derived	52001000	46863000 Derived	5138000	Unavailable	Source 2009-01-02 – 2010-01-01: 262989000 USD Inspect Revenue Open source 2009-01-02 – 2010-01-01: 52001000 USD Inspect Operating Income Open source 2009-01-02 – 2010-01-01: 5138000 USD Inspect Net Income Open source
2010 2010-01-01 – 2010-12-31	217777000	176365000 Derived	41412000	37768000 Derived	3644000	12139000 Derived	Source 2010-01-01 – 2010-12-31: 217777000 USD Inspect Revenue Open source 2010-01-01 – 2010-12-31: 41412000 USD Inspect Operating Income Open source 2010-01-01 – 2010-12-31: 3644000 USD Inspect Net Income Open source 2010-01-01 – 2010-12-31: 25943000 USD Inspect Operating Cash Flow Open source 2010-01-01 – 2010-12-31: 13804000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 217.8M 2010

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20102010-01-01	Revenue	262989000	Revenue: 262989000 Open source
20102010-12-31	Revenue	217777000	Revenue: 217777000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-17.2% 2010

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20102010-01-01	Year over year	No prior comparable period	Revenue: 262989000 Open source
20102010-12-31	Year over year	-17.2%	Revenue: 217777000 Open source Revenue: 262989000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 19% 2010

Net margin 1.7% 2010

Free cash flow margin 5.6% 2010

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20102010-01-01	Operating margin	19.8%	Operating Income: 52001000 Open source Revenue: 262989000 Open source
20102010-12-31	Operating margin	19%	Operating Income: 41412000 Open source Revenue: 217777000 Open source
20102010-01-01	Net margin	2%	Net Income: 5138000 Open source Revenue: 262989000 Open source
20102010-12-31	Net margin	1.7%	Net Income: 3644000 Open source Revenue: 217777000 Open source
20102010-01-01	Free cash flow margin	Not reported	Revenue: 262989000 Open source
20102010-12-31	Free cash flow margin	5.6%	Revenue: 217777000 Open source Operating Cash Flow: 25943000 Open source Capital Expenditure: 13804000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 25.9M 2010

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20102010-01-01	Operating cash flow	Not reported	No source recorded
20102010-12-31	Operating cash flow	25943000	Operating Cash Flow: 25943000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 12.1M 2010

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20102010-01-01	Free cash flow	Unavailable	No source recorded
20102010-12-31	Free cash flow	12139000	Operating Cash Flow: 25943000 Open source Capital Expenditure: 13804000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2010-01-01	Liabilities / assets	Not reported	No source recorded
2010-12-31	Liabilities / assets	Not reported	Total Assets: 697054000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.48× 2010

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2010-01-01	Current assets / current liabilities	Not reported	No source recorded
20102010-12-31	Current assets / current liabilities	1.48×	Current Assets: 87446000 Open source Current Liabilities: 59150000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2009 2009-01-01 – 2009-12-31	Unavailable Not reported for this period.	USD 51.33 million Exact value Exact value: 51331000 USD 2009-01-01 – 2009-12-31: 51331000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · American Renal Holdings Inc. · 2009-12-31 American Renal Holdings Inc. (edgar:1504735) Operating Cash Flow: 51331000 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T15:00:46Z Snapshot: a09bfe715aa9e843feb83d550b3410bfeefdea652b2179faa0f5d02e386742c5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1504735/explain?concept=fundies%3AOperatingCashFlow&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 51331000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1504735/0001193125-11-084560.txt#16896 The citation records this snapshot. The page link may show a newer release later.	USD 15.07 million Exact value Exact value: 15067000 USD 2009-01-01 – 2009-12-31: 15067000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · American Renal Holdings Inc. · 2009-12-31 American Renal Holdings Inc. (edgar:1504735) Capital Expenditure: 15067000 USD Concept: fundies:CapitalExpenditure Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T15:00:46Z Snapshot: a09bfe715aa9e843feb83d550b3410bfeefdea652b2179faa0f5d02e386742c5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1504735/explain?concept=fundies%3ACapitalExpenditure&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 15067000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1504735/0001193125-11-084560.txt#16940 The citation records this snapshot. The page link may show a newer release later.	USD 36.26 million Calculation and evidence 51331000 − 15067000 USD Exact free cash flow: 36264000 USD 2009-01-01 – 2009-12-31: 51331000 USD · Inspect Operating Cash Flow · Source 2009-01-01 – 2009-12-31: 15067000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · American Renal Holdings Inc. · 2009-12-31 American Renal Holdings Inc. (edgar:1504735) Free cash flow: 36264000 USD Concept: free-cash-flow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T15:00:46Z Snapshot: a09bfe715aa9e843feb83d550b3410bfeefdea652b2179faa0f5d02e386742c5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1504735?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 51331000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1504735/0001193125-11-084560.txt#16896 Input fundies:CapitalExpenditure: 15067000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1504735/0001193125-11-084560.txt#16940 The citation records this snapshot. The page link may show a newer release later.
2010 2009-01-02 – 2010-01-01	USD 5.14 million Exact value Exact value: 5138000 USD 2009-01-02 – 2010-01-01: 5138000 USD Inspect Net Income Open source Share or cite Citation for Net Income · American Renal Holdings Inc. · 2010-01-01 American Renal Holdings Inc. (edgar:1504735) Net Income: 5138000 USD Concept: fundies:NetIncome Period: 2009-01-02 to 2010-01-01 Values: Latest reported Published: 2026-11-02T15:00:46Z Snapshot: a09bfe715aa9e843feb83d550b3410bfeefdea652b2179faa0f5d02e386742c5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1504735/explain?concept=fundies%3ANetIncome&period=2010-01-01&surface=latest&period_type=duration&start=2009-01-02&unit=USD&dimensions= Input fundies:NetIncome: 5138000 USD (2009-01-02 to 2010-01-01) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1504735/0001193125-11-084560.txt#11741 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2010 2010-01-01 – 2010-12-31	USD 3.64 million Exact value Exact value: 3644000 USD 2010-01-01 – 2010-12-31: 3644000 USD Inspect Net Income Open source Share or cite Citation for Net Income · American Renal Holdings Inc. · 2010-12-31 American Renal Holdings Inc. (edgar:1504735) Net Income: 3644000 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T15:00:46Z Snapshot: a09bfe715aa9e843feb83d550b3410bfeefdea652b2179faa0f5d02e386742c5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1504735/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:NetIncome: 3644000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1504735/0001193125-11-084560.txt#11741 The citation records this snapshot. The page link may show a newer release later.	USD 25.94 million Exact value Exact value: 25943000 USD 2010-01-01 – 2010-12-31: 25943000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · American Renal Holdings Inc. · 2010-12-31 American Renal Holdings Inc. (edgar:1504735) Operating Cash Flow: 25943000 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T15:00:46Z Snapshot: a09bfe715aa9e843feb83d550b3410bfeefdea652b2179faa0f5d02e386742c5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1504735/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 25943000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1504735/0001193125-11-084560.txt#16896 The citation records this snapshot. The page link may show a newer release later.	USD 13.8 million Exact value Exact value: 13804000 USD 2010-01-01 – 2010-12-31: 13804000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · American Renal Holdings Inc. · 2010-12-31 American Renal Holdings Inc. (edgar:1504735) Capital Expenditure: 13804000 USD Concept: fundies:CapitalExpenditure Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T15:00:46Z Snapshot: a09bfe715aa9e843feb83d550b3410bfeefdea652b2179faa0f5d02e386742c5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1504735/explain?concept=fundies%3ACapitalExpenditure&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 13804000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1504735/0001193125-11-084560.txt#16940 The citation records this snapshot. The page link may show a newer release later.	USD 12.14 million Calculation and evidence 25943000 − 13804000 USD Exact free cash flow: 12139000 USD 2010-01-01 – 2010-12-31: 25943000 USD · Inspect Operating Cash Flow · Source 2010-01-01 – 2010-12-31: 13804000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · American Renal Holdings Inc. · 2010-12-31 American Renal Holdings Inc. (edgar:1504735) Free cash flow: 12139000 USD Concept: free-cash-flow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T15:00:46Z Snapshot: a09bfe715aa9e843feb83d550b3410bfeefdea652b2179faa0f5d02e386742c5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1504735?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 25943000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1504735/0001193125-11-084560.txt#16896 Input fundies:CapitalExpenditure: 13804000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1504735/0001193125-11-084560.txt#16940 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

9 filings · 484 latest values · 484 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001504735, 1504735, edgar:1504735

Also known as AMERICAN RENAL HOLDINGS INC., American Renal Holdings Inc.

American Renal Holdings Inc.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2010 2010-01-01 – 2010-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation